IGF-1 LR3
IGF-1 LR3 is a synthetic protein and lengthened analogue of human Insulin-like Growth Factor 1 (IGF-1). It has been altered to include a 13 amino acid extension on its N-terminus and the substitution of an Arginine for the Glutamic Acid at position 3. These modifications increase the biological activity of IGF-1 LR3 and make it more resistant to degradation, thus extending its half-life.
Structure and Function[edit]
IGF-1 LR3 is similar in structure to Insulin and has a high degree of sequence homology with it. It is a single-chain polypeptide composed of 83 amino acids. The protein is highly anabolic and can promote both muscle cell hyperplasia (an increase in the number of muscle cells) and muscle cell hypertrophy (an increase in the size of muscle cells).
IGF-1 LR3 binds to the IGF-1 receptor, which is found on many cell types in many different tissues. This binding activates the receptor and triggers intracellular signaling pathways that promote cell growth, proliferation, and survival.
Applications[edit]
IGF-1 LR3 has been used in scientific research and has potential applications in medicine and sports. In research, it is often used to study the effects of IGF-1 on cell growth and survival. In medicine, it has potential applications in the treatment of growth disorders, muscle wasting diseases, and metabolic disorders. In sports, it is sometimes used as a performance-enhancing drug, although its use is banned by many sports organizations.
Safety and Side Effects[edit]
The safety and side effects of IGF-1 LR3 are not fully understood, as it is a relatively new substance and has not been extensively studied in humans. However, it is known that IGF-1 can cause hypoglycemia, and it is likely that IGF-1 LR3 can cause similar effects. Other potential side effects include increased risk of cancer, as IGF-1 can promote the growth of cancer cells, and acromegaly, a condition characterized by excessive growth of the hands, feet, and face.
Legal Status[edit]
The legal status of IGF-1 LR3 varies by country. In some countries, it is classified as a prescription drug and can only be obtained with a doctor's prescription. In other countries, it is classified as a controlled substance and its possession, sale, and use are strictly regulated.
Ad. Transform your life with W8MD's Budget GLP-1 injections from $75


W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $75 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian

